Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
System and method of drug disease matching
System and method for periodic body scan differencing
Compositions and methods for the production of S-adenosylmethionine within the body
Extensible file and path renaming during multimedia acquisition
Adaptive transmissions in wireless networks
Non-transitory computer readable storage medium, sound-volume prediction apparatus, and sound-volume prediction method
Method and apparatus for implementing and filtering customized ringing signals
  Randomly Featured Patents
Transistor fabrication methods and structures thereof
Method for measurement of liquid samples
Vane of a vane pump for hydraulic operating medium
Rain and storm water filtration systems
Farm tractor
Bowing sensor for musical instrument
Mount for the fuel nozzle of a gasifier
Method of the treatment of dry nose syndrome
Thermosensitive recording material
Optimized usage of collector resources for performance data collection through even task assignment